Accesswire
30 Jun 2026, 03:30 UTC · 2h ago
Nano One Renews At-The-Market Equity Program
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

Accesswire
30 Jun 2026, 03:30 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.

What the story claims
3 claims · each scored for market impact
Nano One has renewed an At-The-Market (ATM) equity program allowing it to sell up to C$20 million in common shares. — ATM programs create potential downward pressure on share prices due to the threat of equity dilution and increased share supply.
-0.40The company intends to use the net proceeds from the equity issuance to fund ongoing operations and the final stages of its Candiac scale-up. — The need to raise equity for operational expenses and scaling suggests a reliance on external capital rather than organic cash flow.
-0.20The ATM program is designed to complement existing non-dilutive funding support from the governments of Canada, Québec, and the US. — Confirmation of ongoing government support provides a baseline of financial stability and validation of the company's technology.
+0.20Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is renewing an at-the-market equity program to raise up to C$20M, which typically implies potential share dilution for investors.
Mentioned as a strategic collaborator supporting the company's growth strategy.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
4h ago